Temas de la conferencia
The 12th World Bispecific Summit has established itself as the key industry-led networking forum to gain clear insights into the latest discovery, translational and manufacturing advancements, and how to address associated development challenges encountered within this therapeutic modality.
If your research teams are looking to tackle major challenges in bispecific drug functionality, including tumor-specific antigen targeting, binding affinity; or multi-specific antibody formats, this elite co
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/787357-3?pid=4832
Speakers: Nicolas Poirier, Chief Scientific Officer, OSE Immunotherapeutics, Nimish Gera, Head of Biologics, Mythic Therapeutics and more
Información e inscripción:
https://go.evvnt.com/787357-2?pid=4832
Mr. Customer Service
CategoríasMedicina General, Oncología